USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
AESTUS THERAPEUTICS, INC.
Address:
AESTUS THERAPEUTICS, INC.
675 US Highway One
North Brunswick, NJ
Phone:
N/A
URL:
N/A
EIN:
156256016
DUNS:
780470279
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $198,960.00 1
SBIR Phase II $2,408,144.00 1

Award List:

Accelerated Discovery and Development of New Pain Therapeutics

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$198,960.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): More than 25 million people in the United States suffer from neuropathic pain. Currently available drugs include opioids, anti-epileptics, topicals such as lidocaine, NMDA antagonists, and tricyclic antidepressants, no ne of which achieve clinical significance… More

Accelerated Discovery and Development of New Pain Therapeutics

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$2,408,144.00
Agency:
HHS
Principal Investigator:
Tage Honore
Abstract:
DESCRIPTION (provided by applicant): Neuropathic pain is a common complication of cancer, diabetes mellitus, viral infections, and other causes. Although physicians currently employ a variety of treatments to manage moderate to severe neuropathic pain, including non-steroidal anti-inflammatory… More